While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Novavax Inc. closed $11.71 below its 52-week high ($23.86), which the company achieved on June 6th.

Novavax occupies five sites in Montgomery County totaling about 370,000 square feet. Its footprint includes its headquarters ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option. Jessica is a writer on the Wellness team with a focus on health technology ...